Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Weekly Picks
Citigroup
CH
ChadWisperer
Community Contributor
Pole position to benefit from GENIUS Act
The passing of the GENIUS Act establishes a clear regulatory framework for stablecoins, allowing banks like Citi to issue their own stablecoins; Citi Token Services lets Citi position itself as the "killer app" for institutional cross-border payments, absorbing complexities and offering instant, cost-effective solutions; Core business is firing on all cylinders , with record performances in Markets and Wealth, significant share gains in Investment Banking (especially M&A, LevFin, and sponsors), and robust growth in Services and U.S. Personal Banking, all contributing to strong revenue momentum; Highly capital efficient returning $3 billion in capital during the quarter , including $2 billion in share repurchases, part of our $20 billion repurchase plan with a goal of 11% Return on tangible equity (ROTE or ROTCE). ✨ Chat with this narrative: https://notebooklm.google.com/notebook/aa2a6c92-6bd1-495e-beb5-d8d4e6525410 (believe a Google account is required) Background Citigroup Inc.
View narrative
US$233.04
FV
59.0% undervalued
intrinsic discount
6.00%
Revenue growth p.a.
Set Fair Value
16
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
8 days ago
author updated this narrative
IREN
KA
kapirey
Community Contributor
IREN will transform from bitcoin miner to leader in AI infrastructure
Key Highlights Financial Performance (Q3 FY25) Record Revenue : $148.1 million Record Adjusted EBITDA : $83.3 million Record EBITDA : $82.7 million Profit After Tax : $24.2 million Avg. Operating Hashrate : 29.4 EH/s Strong Margins : All-in cash cost per BTC mined at $41k vs.
View narrative
US$21.48
FV
22.8% undervalued
intrinsic discount
49.99%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
XRF Scientific
RO
Robbo
Community Contributor
Behind the Assay: XRF Scientific’s Role in Modern Mining Economics
There’s an old saying that in a gold rush, those who make the money are the ones selling the shovels; and mining service companies have indeed proven to be shrewd investments historically. XRF Scientific holds a strong niche in sample preparation equipment and consumables used in X-ray fluorescence (XRF) and X-ray diffraction (XRD) analysis, which are essential in determining the quality and purity of materials.
View narrative
AU$2.10
FV
4.3% undervalued
intrinsic discount
9.68%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
8 days ago
author updated this narrative
All companies
Popular
Undervalued
Overvalued
Community Investing Ideas
Load previous narratives
Investigator Resources
RO
RockeTeller
Community Contributor
If silver hits $100 per ounce
To estimate Investigator Resources' stock price if silver hits $100 per ounce, let's consider the following factors based on the data provided: ### Key Inputs: - Annual silver production : 4 million ounces per year. - AISC (All-In Sustaining Cost) : $13 per ounce.
View narrative
AU$1.80
FV
98.4% undervalued
intrinsic discount
0%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 months ago
author updated this narrative
First Majestic Silver
RO
RockeTeller
Community Contributor
Silver's stock price if silver hits $100 per ounce
To estimate First Majestic Silver's stock price if silver hits $100 per ounce, we can use a free cash flow (FCF) valuation method based on the company's projected performance at higher silver prices. Here's how to break it down: ### Key Assumptions from the Data: - Projected Free Cash Flow (FCF) at $100 silver: $2 billion.
View narrative
US$66.00
FV
87.3% undervalued
intrinsic discount
67.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 months ago
author updated this narrative
HeartCore Enterprises
ON
Ontological
Community Contributor
A Diversification Worth a Look-HTCR
Digital Transformation Specialist and IPO Consultant, HeartCore Enterprises Catalysts -Products or Services that Could Move Sales or Earnings Meaningfully 1. Growth: The global Customer Experience Management (CXM) market is expected to grow at a compound annual growth rate of 15.2% from 2024 to 2032, positioning HeartCore positively in this sector.
View narrative
US$0.84
FV
44.2% undervalued
intrinsic discount
12.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
9 months ago
author updated this narrative
Clear Secure
DA
DailyInvestors
Community Contributor
A Technology Company on a whole different Level
Stock Market Company of the Month: "YOU " Clean Secure" has been making recent headlines from various Money Management Corporations. YOU in the past three months has reached over 80% gain.
View narrative
US$50.00
FV
39.8% undervalued
intrinsic discount
15.18%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 months ago
author updated this narrative
Progressive
WA
WallStreetWontons
Community Contributor
PGR: Pricing Flexibility and First-Mover Telematics Innovation Offers Steady Growth and Competition
Catalysts The Progressive Corporation (PGR) has several products and services that could significantly impact its sales and earnings: Personal Auto Insurance : This remains a core product for Progressive, contributing substantially to its revenue. Special Lines Products : These include insurance for motorcycles, ATVs, RVs, watercraft, and snowmobiles.
View narrative
US$399.21
FV
39.6% undervalued
intrinsic discount
13.10%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
10 months ago
author updated this narrative
CVS Health
JU
julio
Community Contributor
CVS VALUATION
Bulls CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the organization. The firm's entry into provider services has the potential to improve returns for all of CVS' segments if it can help patients more easily and cost-effectively manage chronic conditions through early intervention.
View narrative
US$62.09
FV
3.9% undervalued
intrinsic discount
7.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
10 months ago
author updated this narrative
EuroSports Global
ON
Ontological
Community Contributor
The Hidden Investment Gem in Singapore?
Catalysts Are there any products or services that could move sales or earnings meaningfully? Entry into the EV market with the Scorpio Electric X1 Are there any industry tailwinds this stock is benefitting or hindered from?
View narrative
S$0.72
FV
84.0% undervalued
intrinsic discount
12.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
3
users have followed this narrative
10 months ago
author updated this narrative
Exxon Mobil
RI
Richard_Bowman
Equity Analyst and Writer
ExxonMobil's Focus On Margins Rather Than Growth Will Help It Cash In On Tight Supply
Key Takeaways Oil supply will remain tight leading to a higher and more volatile oil price. Volatility will favor large well capitalized energy companies.
View narrative
US$126.39
FV
11.8% undervalued
intrinsic discount
2.94%
Revenue growth p.a.
Set Fair Value
13
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
10 months ago
author updated this narrative
Synektik Spólka Akcyjna
PH
Phetuvov
Community Contributor
Cardiac marker could be a hit
In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.
View narrative
zł204.19
FV
2.2% overvalued
intrinsic discount
8.49%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
10 months ago
author updated this narrative
Value any company in seconds
Popular companies